Lessons for Oral Bioavailability: How Conformationally Flexible Cyclic Peptides Enter and Cross Lipid Membranes

Area of Science:

• Biochemistry
• Computational Chemistry
• Pharmacology

Background:

• Cyclic peptides offer expanded therapeutic potential due to their unique structural and chemical properties.
• However, their passive membrane permeability is often limited, hindering their development as drugs.
• The precise mechanisms of cyclic peptide membrane permeation remain poorly understood, impeding rational drug design.

Purpose of the Study:

• To elucidate the atomistic mechanisms governing the passive membrane permeation of cyclic peptides.
• To identify key molecular interactions and conformational changes during peptide translocation.
• To provide insights for the rational design of cyclic peptides with improved membrane permeability.

Main Methods:

• Molecular dynamics simulations were employed to model cyclic peptide interactions with a lipid bilayer.
• Analysis focused on peptide-lipid interactions, conformational dynamics, and translocation pathways.
• Key events such as membrane insertion, interfacial positioning, and leaflet crossing were investigated.

Main Results:

• Cyclic peptide side chains act as "molecular anchors" facilitating initial membrane insertion.
• Peptides adopt a specific orientation at the polar/apolar lipid interface, forming a "closed" permeable conformation.
• Translocation across the membrane involves a distinct anchoring and flipping mechanism.

Conclusions:

• This study provides unprecedented atomistic detail on cyclic peptide membrane permeation.
• Understanding these mechanisms offers critical design considerations for enhancing peptide drug delivery.
• The findings pave the way for developing more effective cyclic peptide-based therapeutics.